Analyst Ratings for Opus Genetics (IRD)
IRD Rating Summary
IRD Price Target Summary
- Highest: $16.00 (Guggenheim)
- Lowest: $7.00 (Piper Sandler)
- Average: $10.19
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$10.19 (+211.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | RBC Capital | Lisa Walter | New Coverage | Outperform (N/A) |
10.00 (N/A) |
4.08 (3.27) |
-19.85% | Details |
| 6/4/2026 | Guggenheim | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
16.00 (N/A) |
4.20 (3.27) |
-22.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
